PCT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PureCycle Technologies Inc (PCT) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has potential due to its patented technology and a large addressable market, the financial performance is weak, hedge funds are selling, and the commercial ramp delays create uncertainty. The technical indicators suggest a neutral to slightly positive trend, but there are no strong proprietary trading signals to justify immediate action.
The MACD is positive at 0.22, indicating a slight bullish momentum, but it is contracting. RSI is at 77.838, which is neutral and does not indicate overbought or oversold conditions. Moving averages are converging, suggesting no strong directional trend. The pre-market price of $7.29 is above the pivot point of $6.621, indicating mild upward momentum, with resistance at $7.429.
Abundance Wealth Counselors increased its stake significantly, showing confidence in the company's long-term potential. Innventure's capital allocation strategy aims to support long-term growth and shareholder returns.
Hedge funds are selling heavily, with an 808.33% increase in selling activity last quarter. Analysts have lowered price targets due to delays in the commercial ramp and weak Q4 results. Financial performance is poor, with significant YoY declines in net income and EPS.
In Q4 2025, revenue remained flat at $2.695 million YoY. Net income dropped significantly by -70.95% YoY to -$18.787 million, and EPS fell by -74.36% YoY to -0.1. Gross margin remained at 100%, but overall financials indicate weak performance.
Analysts have lowered price targets from $16 to $14, citing delays in the commercial ramp and reduced revenue forecasts for 2026. However, they maintain an Outperform and Overweight rating, showing long-term optimism based on the company's technology and market potential.
